Johnson & Johnson buy SVB Leerink LLC
Start price
23.01.25
/
50%
€141.20
Target price
23.01.26
€162.54
Performance (%)
31.70%
End price
24.01.26
€185.96
Summary
This prediction ended on 24.01.26 with a price of €185.96. With a performance of 31.70% the BUY prediction by SVB_Leerink_LLC was a big success. Dividends of €1.19 are taken into consideration when calculating the performance. SVB_Leerink_LLC has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Johnson & Johnson | 0.129% | 0.129% | 33.195% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Leerink Partners from $182.00 to $169.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
In the thread Trading Johnson & Johnson
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten